Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BKO
|
|||
| Drug Name |
Etripamil
|
|||
| Synonyms |
UNII-S82A18Y42P; S82A18Y42P; 1593673-23-4; Etripamil [USAN:INN]; Etripamil (USAN/INN); CHEMBL3707312; DB12605; Benzoic acid, 3-(2-(((4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl)methylamino)ethyl)- , methyl ester; D10932
Click to Show/Hide
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Phase 2 | [1] | |
| Paroxysmal supraventricular tachycardia [ICD-11: BC81.Z] | Phase 2 | [2] | ||
| Company |
Milestone Pharmaceuticals Quebec, Canada
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H36N2O4
|
|||
| Canonical SMILES |
CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC
|
|||
| InChI |
1S/C27H36N2O4/c1-20(2)27(19-28,23-11-12-24(31-4)25(18-23)32-5)14-8-15-29(3)16-13-21-9-7-10-22(17-21)26(30)33-6/h7,9-12,17-18,20H,8,13-16H2,1-6H3/t27-/m0/s1
|
|||
| InChIKey |
VAZNEHLGJGSQEL-MHZLTWQESA-N
|
|||
| CAS Number |
CAS 1593673-23-4
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02296190) Efficacy and Safety of Intranasal MSP-2017 for the Conversion of PSVT to Sinus Rhythm (NODE-1). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.